MEXC Lists Moderna Tokenized Stock Amid Price Surge
MEXC has listed the MRNAON/USDT trading pair on its Spot platform, giving users access to U.S. biotech exposure through tokenized stocks.
This move comes after Moderna's stock price soared 177% on August 19, 2026, following the announcement of positive trial results for their mRNA cancer vaccine in combination with Keytruda.
The listing reflects MEXC's collaboration with Ondo, which aims to bring traditional public securities on-chain through tokenized assets, enabling investors outside the United States to invest in publicly traded U.S. securities.